GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Modalis Therapeutics Corp (TSE:4883) » Definitions » Other Liabilities for Insurance Companies

Modalis Therapeutics (TSE:4883) Other Liabilities for Insurance Companies


View and export this data going back to 2020. Start your Free Trial

What is Modalis Therapeutics Other Liabilities for Insurance Companies?

Other Liabilities for Insurance Companies only applies to insurance companies.


Modalis Therapeutics (TSE:4883) Business Description

Industry
Traded in Other Exchanges
N/A
Address
16-5 Nihombashi-Kabuto-cho, Chuo-ku, Tokyo, JPN, 103-0026
Modalis Therapeutics Corp is a drug development company. It is engaged in research and development of Gene Therapy using core platform technology, non-editing CRISPR technology (CRISPR-GNDM). The company's products in pipeline are MDL-201, MDL-202, MDL-204, MDL-205, MDL-206, MDL-101, and MDL-102.